NCT05194072 2026-01-09
A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors
Seagen Inc.
Phase 1 Terminated
Seagen Inc.
Institut Bergonié
Johns Hopkins University
UMC Utrecht
University of Regensburg
University Hospital Tuebingen
Universitätsmedizin Mannheim
University Hospital, Gasthuisberg
Centre Hospitalier Universitaire de Nice